Amor Hajri

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index1.2kcitations52works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Research and Treatments(18), Virus-based gene therapy research(16), Neuroendocrine Tumor Research Advances(9), Pancreatic and Hepatic Oncology Research(8), Neuropeptides and Animal Physiology(8)

Publications52 total

Intracholecystic papillary neoplasm of the gallbladder in an elderly patient: A case report and updated literature review
International Journal of Case Reports in Surgery·2025Open Access
Data from Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV
2023Open Access
Supplementary Data from Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV
2023Open Access
Data from Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV
2023Open Access
Supplementary Data from Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV
2023Open Access
Medullary Carcinoma of the Colon : A Case Study
SPIRE - Sciences Po Institutional REpository·2022
Novel 6-aryl-7-alkyl/aryl-[1,2,4]triazolo[4,3-a][1,3,5]triazine-5(6H)-thiones, processes for their preparation, characterization and evaluation of their in vitro antioxidant activity
Bulletin of the Chemical Society of Ethiopia·2022· 3 citedOpen Access
Oncosuppressive Suicide Gene Virotherapy “PVH1-yCD/5-FC” for Pancreatic Peritoneal Carcinomatosis Treatment: NFκB and Akt/PI3K Involvement
PLoS ONE·2013· 12 citedOpen Access
Gene Therapy for Cancer Treatment – State of the Art
BioValley monographs·2012· 1 cited
Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer
Nanomedicine Nanotechnology Biology and Medicine·2011· 98 cited
Gemcitabine-Based Chemogene Therapy for Pancreatic Cancer Using Ad-dCK::UMK GDEPT and TS/RR siRNA Strategies
Neoplasia·2009· 78 citedOpen Access
Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV
Clinical Cancer Research·2009· 92 cited
Thérapie génique d'un adenocarcinome pancréatique par ciblage de l'expression de la purine nucléoside phosphorylase d' e. coli a l'aide d'un promoteur de marqueur tumoral
2008
Telomerase Transcriptional Targeting of Inducible Bax/TRAIL Gene Therapy Improves Gemcitabine Treatment of Pancreatic Cancer
Molecular Therapy·2007· 16 citedOpen Access
Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine
International Journal of Oncology·2007· 22 citedOpen Access
K‐ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment
Cancer Science·2007· 88 citedOpen Access
949. Oncolytic Autonomous Parvovirus (rH1-yCD) Targeting with P4/Carcinoembryonic Antigen Chimeric Promoter for Virotherapy of Pancreatic Cancer
Molecular Therapy·2006Open Access
Activité oncolytique du parvovirus H1 (PV-H1) sur différents modèles de cancer de pancréas exocrine
Gastroentérologie Clinique et Biologique·2005
Efficacité des gènes proaptotiques : trail-bax sur des modèles de cancer du pancréas : visualisation par imagerie moléculaire
Gastroentérologie Clinique et Biologique·2005
Transcriptional tumor‐selective promoter targeting of <i>E. coli</i> purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy
The Journal of Gene Medicine·2004· 17 cited
page 1 of 3Next →

Frequent Co-authors

Marc Aprahamian(34), Christiane Damgé(14), Séverine Wack(13), Ginette Balboni(10), Jacques Marescaux(9), Soukaina Réjiba(7), Sophie J. Deharvengt(7), Serge Évrard(5), Assia L. Angelova(5), Svitlana P. Grekova(5), Barbara Leuchs(5), Nathalia A. Giese(5), Christiane Dinsart(5), Alexia Herrmann(5), Jean Rommelaere(5), Zahari Raykov(5), C. Parmentier(4), Christelle Bigand(3), V. Tassetti(3), F. Heisel(3)